ArticleDrug design, development and therapy2026

Indication Expansion Dynamics and Trial Characteristics of Novel Multi-Indication Anti-Cancer Drugs in China (2000-2024): A Cross-Sectional Study.

Xiaoyi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.